Seroquel and Diprolene drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Seroquel (quetiapine fumarate) and Diprolene (betamethasone dipropionate). Common drug interactions include bronchitis among females and diabetes mellitus among males.

The phase IV clinical study analyzes what interactions people have when they take Seroquel and Diprolene. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Seroquel?

Seroquel has active ingredients of quetiapine fumarate. It is often used in bipolar disorder. eHealthMe is studying from 120,285 Seroquel users. Check the latest studies of Seroquel.

What is Diprolene?

Diprolene has active ingredients of betamethasone dipropionate. eHealthMe is studying from 1,048 Diprolene users. Check the latest studies of Diprolene.



On Jul, 11, 2026

20 people who take Seroquel and Diprolene together, and have interactions are studied.

Seroquel and Diprolene drug interactions.

What are the common drug interactions of Seroquel and Diprolene, by gender? *:

female:

  1. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  2. Fall
  3. Injection site pain
  4. Abdominal distension
  5. Bedridden
  6. Chronic kidney disease
  7. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  8. Constipation
  9. Diarrhoea
  10. Drug abuser

male:

  1. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  2. Blood glucose increased
  3. Cataract (clouding of the lens inside the eye)
  4. Emotional distress
  5. Hypersexuality
  6. Intraocular pressure increased
  7. Pathological gambling
  8. Somnolence (a state of near-sleep, a strong desire for sleep)
  9. Visual acuity reduced (reduced clearness of vision)

What are the common drug interactions of Seroquel and Diprolene, by age (0-1 to 60+)? *:

0-1:

  1. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Foot deformity (functional disability of foot)
  2. Impaired healing
  3. Injection site bruising
  4. Injection site pain
  5. Loss of consciousness
  6. Menorrhagia (an abnormally heavy bleeding and prolonged menstrual period at regular intervals)
  7. Procedural pain

40-49:

  1. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  2. Blood glucose increased
  3. Cataract (clouding of the lens inside the eye)
  4. Intraocular pressure increased
  5. Visual acuity reduced (reduced clearness of vision)

50-59:

  1. Death
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  3. Incoherent (talking in a confused and unclear way)
  4. Sleep disorder
  5. Sleep talking (talking during sleeping)
  6. Sudden death
  7. Syncope (loss of consciousness with an inability to maintain postural tone)

60+:

  1. Fall
  2. Abdominal distension
  3. Fatigue (feeling of tiredness)
  4. Gait disturbance
  5. Haematocrit decreased
  6. Haematoma (collection of blood outside the blood vessels)
  7. Haemoglobin decreased
  8. Head injury
  9. Hypersensitivity
  10. Hyperventilation

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 40.00%
  2. Depression: 7 people, 35.00%
  3. Stress And Anxiety: 6 people, 30.00%
  4. Insomnia (sleeplessness): 6 people, 30.00%
  5. Asthma: 6 people, 30.00%
  6. High Blood Pressure: 5 people, 25.00%
  7. Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 4 people, 20.00%
  8. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 20.00%
  9. Dermatitis Contact (skin reaction (dermatitis) resulting from exposure to allergens): 4 people, 20.00%
  10. Migraine (headache): 4 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Seroquel and Diprolene?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Seroquel and Diprolene:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Seroquel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Diprolene:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Seroquel and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Diprolene and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on quetiapine fumarate and betamethasone dipropionate (the active ingredients of Seroquel and Diprolene, respectively), and Seroquel and Diprolene (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: